For example, application 1411 was underpinned by the evidence linking BRCA1/2 testing in breast cancer probands, and this was used to support public funding for BRCA1/2 testing in breast cancer probands and ovarian cancer probands. The gene discussed is BRCA1; the disease is ovarian carcinoma.